Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 121 mln. 83,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,54 mln. -24,31 mln. | Nettowinst (verlies) 2021 | -52 mln. -71,09 mln. -48,61 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 684K 468K | Nettoliquiditeiten 2021 | 1,77 mln. 2,43 mln. 1,66 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,13% | 4,49 mld. | |
-9,75% | 3,06 mld. | |
+2,14% | 3,04 mld. | |
-6,82% | 2,61 mld. | |
+47,87% | 1,81 mld. | |
+0,09% | 1,66 mld. | |
-7,89% | 1,63 mld. | |
-12,97% | 1,55 mld. | |
+33,40% | 1,41 mld. |